by David J. Weber, MD, MPH
This summary is based on the just released CDC/ACIP statement “Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States,
2016–17 Influenza Season (http://www.cdc.gov/mmwr/volumes/65/rr/rr6505a1.htm).
Influenza viruses typically circulate widely in the United States annually, from the late Fall through early Spring. Although most persons who become infected with influenza viruses will recover without sequelae, influenza can cause serious illness and death, particularly among older adults, very young children, pregnant women, and those with chronic medical conditions. During 31 seasons from the 1976–77 through the 2006–07 season, estimated influenza-associated deaths ranged from approximately 3,300 to 49,000 annually. Annual influenza vaccination is the primary means of preventing influenza and its complications. A variety of different types of influenza vaccine are available. Routine annual influenza vaccination for all persons aged ≥6 months who do not have contraindications has been recommended by CDC and ACIP since 2010.
Primary changes and updates in recommendations are included in the CDC/ACIP statement. Routine annual influenza vaccination of all persons aged ≥6 months without contraindications continues to be recommended. No preferential recommendation is made for one influenza vaccine product over another for persons for whom more than one licensed, recommended product is otherwise appropriate. Updated information and guidance in this document includes the following: Read More →